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Vitamin D deficiency is a common health problem in Saudi Arabia especially in children and adolescents. Many
studies have reported the relation between low 25-Hydroxyvitamin D (25(OH)D) levels with cardiovascular diseases
risk factors as well as cardiovascular events, including stroke, myocardial infarction, and congestive heart failure. This
study was conducted to evaluate the effect of 25(OH)D deficiency on the myocardial function and other
echocardiographic variables in adolescent, using tissue Doppler imaging (TDI) and to correlate these parameters
with 25(OH)D level. The study included 84 healthy adolescents, consecutively selected from adolescents attending the
outpatient clinic of Saad Specialist Hospital, KSA between September 2013 and October 2014. The study population
was classified into two groups; vitamin D deficient group with 25(OH)D level less than 20 ng/mL and normal vitamin D
(control group) with 25(OH)D equal or more than 30 ng/mL. Both groups were subjected to measuring hemoglobin
level, serum albumin, creatinine, total calcium, Phosphorous, intact parathyroid hormone (iPTH), B-type natriuretic
peptide (BNP), and 25(OH)D levels. Both conventional and pulsed wave TDI were done for all participants. TDI
measurements showed significant higher LV Tei Index and RV Tei index when compared to the control group
(0.61 ± 0.11 Vs 0.32 ± 0.05 p < 0.0001), (0.54 ± 0.14 Vs 0.40 ± 0.06 p < 0.0001) respectively. Mitral and tricuspid annular
systolic velocities were significantly lower in vitamin D deficient group (6.99 ± 1.92 Vs 10.69 ± 0.31 cm/sec p < 0.0001 and
12.30 ± 2.14 Vs 13.89 ± 0.29 p < 0.0001 respectively). The mitral and tricuspid E/Em ratio was significantly higher in
vitamin D deficient group than control group (p < 0.0001, p 0.005) respectively. Left ventricular internal diameter at end-
diastole (LVIDd) was significantly higher in vitamin D deficient group (44.72 ± 6.33 Vs 40.36 ± 6.21 p 0.003). Serum 25
(OH)D level showed significant negative correlation with LV Tei index (r = 0.668, p < 0.0001), RV Tei index (r = 0.421,
p < 0.0001). Vitamin D deficiency is associated with subtle systolic and diastolic myocardial dysfunction in Saudi
adolescents. TDI is a useful tool for detecting early changes in the myocardium in this particular group.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Abbreviations
25 (OH) D 25-Hydroxyvitamin D
BNP B-type natriuretic peptide
BSA Body Surface Area
BW Body weight
CVD cardiovascular diseases
DBP diastolic blood pressure
DT deceleration time
FS fractional shortening
ICT isovolumetric contraction time
iPTH intact parathyroid hormone
IRT isovolumetric relaxation time
IVSd interventricular septal thickness at diastole
IVSs interventricular septal thickness at systole
LVIDd left ventricular diameter at end diastole
LVIDs left ventricular diameter at end systole
LVPWd left ventricular posterior wall thickness at
diastole
LVPWs left ventricular posterior wall thickness at
systole
RVDd right ventricular diameter at end diastole
SBP systolic blood pressure
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Calcifediol, also known as 25-hydroxyvitaminD (25(OH)D) plays an important role in the
maintenance of bone health, principally via its
effects on calcium metabolism. In the past decade,
a growing body of evidence has suggested that
25(OH)D may also play an important homeostatic
role in other organ systems [1]. This hypothesis is
supported by the broad tissue distribution of
25(OH)D receptors in nonskeletal organs [2,3].
Accordingly, inadequate 25(OH)D status may
have extraskeletal as well as skeletal conse-
quences. More recent evidence suggests that
25(OH)D may also play a protective role in many
chronic conditions, including cancer, autoim-
mune, kidney, and cardiovascular diseases
(CVD) [4].
Vitamin D deficiency is defined as a 25(OH)D
level of <20 ng/mL and insufficiency as
<30 ng/mL but >20 ng/mL. A level P30 ng/mL is
considered sufficient [5]. Observational studies
have associated low 25(OH)D levels with CVD risk
factors, including hypertension, hyperlipidemia,
diabetes, and metabolic syndrome, as well as with
cardiovascular events, including stroke, myocar-
dial infarction, and congestive heart failure [6].
There are several mechanisms by which
25(OH)D may be associated with atherosclerosis
and CVD events and numerous recent studies
have found high rates of CVD among patients
with lower levels of 25(OH)D [7,8].
The aim of this study was to evaluate the effect
of a 25(OH)D deficiency on the myocardial func-
tion and other echocardiographic variables in
healthy adolescents, using tissue Doppler imaging
(TDI) and to correlate these parameters with
25(OH)D level.Material and methods
This was a prospective study, performed
between September 2013 and October 2014.
Written informed consent was obtained from the
family or the legal representative of the adolescent
participating in this study. The Institutional
Review Board of Saad Specialist Hospital
approved the study.
Our study population consisted of 84 healthy
adolescents, consecutively selected from adoles-
cents attending the outpatient clinic of Saad
Specialist Hospital, KSA.
All the participants were healthy, and attended
only for a school medical check-up before the firstsemester; their ages ranged from 12 years to
16 years. We excluded anyone with acute or
chronic disease, under treatment that could influ-
ence their 25(OH)D level, or adolescents with
25(OH)D levels of 20–30 ng/mL. According to the
level of a 25(OH)D, the study population was clas-
sified into two groups: the vitamin D deficient
group, with 25(OH)D level <20 ng/mL; and the
control group with normal vitamin D, with
25(OH)DP 30 ng/mL.
All the studied adolescents were subjected to
complete history taking, thorough clinical exami-
nation, and laboratory tests including: hemoglo-
bin level, serum albumin, creatinine, total
calcium, phosphorous, intact parathyroid hor-
mone (iPTH), B-type natriuretic peptide (BNP),
and 25(OH)D levels. The serum concentration of
25(OH)D was measured using radioimmunoassay
(reference range, 9.0–37.6 ng/mL) [9].
Echocardiographic measurements
Echocardiographic measurements were done
using (SONOS-5500; Hewlett Packard, Andover,
MA, USA) with an 8 MHz probe incorporating
color flow, pulsed wave, continuous wave
Doppler, and pulsed-wave TDI. Images were
recorded on videotape. All measurements were
performed by a single investigator (M.M.), who
was blinded to the patients’ 25(OH)D status. The
details of conventional echocardiography and
TDI measurements were as previously described
[10]. All parameters were measured during end
Figure 1. Example of calculations of mitral annular tissue Doppler imaging velocity measurements. Am = late diastolic annular velocity;
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were measured and averaged for each measure-
ment [11]. TDI recordings were adequately
obtained in all patients (Fig. 1). TDI parameters
indicative of the systolic function included peak
annular systolic (Sm) velocity and isovolumetric
contraction time (ICT). Variables indicative of
diastolic function included early annular diastolic
velocity (Em), late annular diastolic velocity
(Am), Em/Am ratio, the ratio of early filling veloc-
ity wave (E)/Em ratio, and isovolumetric relax-
ation time (IRT). Variables indicative of global
myocardial dysfunction included the Tei index.
The intraobserver variability for measurements
of mitral Sm velocity, tricuspid Sm velocity, right
ventricular (RV) Tei index, and left ventricularTable 1. Clinical and laboratory characteristics of the studied grou
Vitamin D deficient grou
Age (y) 14.08 ± 2.01
Male ratio 24 (60%)
BW (kg) 32.49 ± 8.72
Height (cm) 135.43 ± 17.29
BSA (m2) 1.10 ± 0.20
SBP (mmHg) 110.50 ± 15.07
DBP (mmHg) 81.00 ± 11.78
Hemoglobin (g/dL) 13.0 ± 1.2
Serum albumin (g/dL) 4.42 ± 1.12
Serum creatinine (mg/dL) 0.9 ± 0.2
25(OH)D level (ng/mL) 17.62 ± 4.6
Serum phosphorus (mg/dL) 4.14 ± 0.37
Serum calcium (mg/dL) 7.83 ± 1.36
iPTH (pg/mL) 70.5 ± 5.25
BNP level (pg/mL) 33.62 ± 11.14
25(OH)D = 25 hydroxyvitamin D; BNP = B type natriuretic peptide; BSA =
iPTH = intact parathyroid hormone; SBP = systolic blood pressure.(LV) Tei index showed high correlation coeffi-
cients and low variability (r = 0.84 for mitral Sm
velocity, r = 0.91 for tricuspid Sm velocity, r = 0.94
for LV Tei index, and r = 0.93 for RV Tei index).Statistical analysis
Data are presented as mean ± standard devia-
tion. The Chi-square test (or Fisher exact test for
expected value of <5) was used for analysis of cat-
egorical variables. Continuous variables with
Gaussian distribution were analyzed using the
unpaired t test for between-group comparisons.
For continuous variables with non-Gaussian dis-
tribution, the Mann–Whitney U test was used for
between-group analyses. Pearson’s correlationps.
p (n = 30) Control group (n = 54) p
13.93 ± 1.06 0.82
29 (72%) –
31.63 ± 9.04 0.66
131.35 ± 12.72 0.23
1.06 ± 0.18 0.38
113.50 ± 12.25 0.76
79.88 ± 11.59 0.06
12.0 ± 1.1 0.87
4.62 ± 0.85 0.51
0.8 ± 0.3 0.18
36.20 ± 1.4 <0.000
3.89 ± 0.95 0.38
9.77 ± 0.96 <0.000
42.12 ± 3.23 <0.000
10.07 ± 1.92 <0.000
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We studied 84 healthy adolescents aged
12–16 years; the vitamin D deficient group
included 30 adolescents (age 14.08 ± 2.01 years),
while the remaining 54 adolescents (age
13.93 ± 1.06 years) were in the control group.
Demographic, clinical, and laboratory data for
the groups studied are shown in Table 1. There
were no significant differences between groups
regarding age, body weight, height, body surface
area, systolic blood pressure, and diastolic blood
pressure. Additionally, no significant differences
were reported in hemoglobin, serum creatinine,
albumin, and phosphorous levels between both
groups. The vitamin D deficient group showed
significant lower serum 25(OH)D and total serum
calcium levels when compared with the second
group (p < 0.0001). There were significantly higher
serum iPTH and BNP levels in the vitamin D defi-
cient group when compared with the second
group (p < 0.0001).
Two-dimensional, M-mode, and conventional
Doppler echocardiographic parameters of the
studied groups are given in Table 2. No significant
differences were found in right ventricular diame-
ter at end diastole, left ventricular diameter at
end systole, interventricular septal thickness atTable 2. Two-dimensional, M mode and conventional Doppler ech
Vitamin D deficient group (n = 30
RVDd (mm) 10.83 ± 2.69
LVIDd (mm) 44.72 ± 6.33
LVIDs (mm) 29.25 ± 6.84
IVSd (mm) 10.50 ± 3.38
IVSs (mm) 12.77 ± 3.32
LVPWd (mm) 8.67 ± 2.95
LVPWs (mm) 9.87 ± 2.93
FS (%) 33.17 ± 5.55
Mitral inflow
E wave (m/s) 1.16 ± 0.23
A wave (m/s) 1.02 ± 0.20
E/A ratio 1.07 ± 0.39
IVRT (ms) 79.38 ± 13.45
DT (ms) 199.25 ± 37.03
Tricuspid inflow
E wave (m/s) 0.64 ± 0.16
A wave (m/s) 0.56 ± 0.19
E/A ratio 1.24 ± 0.38
DT (ms) 113.38 ± 35.05
DT = deceleration time; FS = fraction shortening; IVRT = isovolumetric r
IVSs = interventricular septal thickness at systole; LVIDd = left ventricular di
LVPWd = left ventricular posterior wall thickness at diastole; LVPWs = left v
diameter at end diastole.diastole, interventricular septal thickness at sys-
tole, left ventricular posterior wall thickness at
diastole, or left ventricular posterior wall thickness
at systole between both groups, but there was sig-
nificantly increased left ventricular diameter at
end diastole in the vitamin D deficient group
(p = 0.003). Left ventricular systolic function, mea-
sured by fractional shortening (FS), showed no
significant difference between groups.
Left ventricular diastolic function evaluated by
conventional Doppler method showed no signifi-
cant differences in mitral early (E), late (A) dias-
tolic velocities, mitral E/A ratio, mitral
isovolumetric relaxation time, and mitral deceler-
ation time between groups. Diastolic evaluation
of the right ventricle showed no significant differ-
ence in tricuspid E and A diastolic velocities, tri-
cuspid E/A ratio, or tricuspid deceleration time.TDI
TDI parameters of both lateral mitral annulus
and lateral tricuspid annulus are shown in
Table 3. We found significantly lower Sm velocity
(p < 0.0001), Em velocity (p < 0.0001), and mitral
annular Em/Am ratio (p < 0.0001) but higher Am
velocity (p = 0.009) in the vitamin D deficient
group in comparison to the control group. The
vitamin D deficient group had significantly pro-
longed mitral IRT (p < 0.0001) and mitral ICT
(p < 0.0001) compared with controls. The mitral
E/Em ratio was significantly higher in vitamin Docardiographic parameters between the studied groups.
) Control group (n = 54) p
11.81 ± 2.63 0.10
40.36 ± 6.21 0.003
26.75 ± 4.82 0.06
11.21 ± 2.92 0.07
11.73 ± 2.75 0.13
9.92 ± 3.02 0.09
10.15 ± 3.05 0.08
34.84 ± 8.55 0.32
0.91 ± 0.14 0.06
0.86 ± 0.12 0.07
0.97 ± 0.25 0.81
75.60 ± 4.79 0.27
184.25 ± 11.49 0.74
0.65 ± 0.13 0.84
0.50 ± 0.12 0.08
1.33 ± 0.28 0.23
111.28 ± 34.52 0.99
elaxation time; IVSd = interventricular septal thickness at diastole;
ameter at end diastole; LVIDs = left ventricular diameter at end systole;
entricular posterior wall thickness at systole; RVDd = right ventricular


















r = - 0.770, p<0.0001
Figure 2. Negative correlation between serum 25-hydroxyvitamin D
(25(OH)D) level and serum B type natriuretic peptide (BNP) level.















r = - 0.668, p <0.0001
Figure 3. Negative correlation between serum 25-hydroxyvitamin D









Table 3. Tissue Doppler imaging-derived variables between the studied groups.
Vitamin D deficient group (n = 30) Control group (n = 54) p
Mitral annulus
Sm (cm/s) 6.99 ± 1.92 10.69 ± 0.31 <0.0001
Em (cm/s) 10.27 ± 1.84 18.63 ± 1.38 <0.0001
Am (cm/s) 13.39 ± 2.49 11.67 ± 3.19 0.009
Em/Am ratio 0.77 ± 0.12 1.72 ± 0.514 <0.0001
ICT (ms) 85.12 ± 12.49 77.36 ± 1.39 <0.0001
IRT (ms) 88.00 ± 16.20 62.38 ± 2.39 <0.0001
Mitral E/Em 8.51 ± 2.17 5.90 ± 0.98 <0.0001
Tricuspid annulus
Sm (cm/s) 12.30 ± 2.14 13.89 ± 0.29 <0.0001
Em (cm/s) 13.21 ± 3.45 16.29 ± 1.29 <0.0001
Am (cm/s) 15.97 ± 5.49 10.54 ± 1.43 <0.0001
Em/Am ratio 0.89 ± 0.31 1.54 ± 0.07 <0.0001
ICT (ms) 62.62 ± 11.98 57.60 ± 8.85 0.040
IRT (ms) 68.25 ± 13.05 61.58 ± 2.11 0.002
Tricuspid E/Em 5.71 ± 1.01 4.03 ± 0.6 0.005
LV Tei index 0.61 ± 0.11 0.32 ± 0.05 <0.0001
RV Tei index 0.54 ± 0.14 0.40 ± 0.06 <0.0001
Am = late diastolic annular velocity; E/Em = ratio of early filling velocity wave/early diastolic annular velocity; Em = early diastolic annular velocity;
ICT = isovolumetric contraction time; IRT = isovolumetric relaxation time; LV = left ventricular; RV = right ventricular; Sm = peak systolic annular
velocity.
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Similar findings were observed at the lateral tri-
cuspid annulus: significant lower tricuspid annu-
lar Sm velocity (p < 0.0001), tricuspid annular
early diastolic velocity (Em) (p < 0.0001), and tri-
cuspid annular Em/Am ratio (p < 0.0001), but
higher tricuspid Am velocity (p < 0.0001) and
higher tricuspid E/Em ratio (p = 0.005) in the vita-
min D deficient group compared with the control
group. Both Tricuspid ICT and ICT were signifi-
cantly prolonged in the vitamin D deficientadolescents when compared with control group
(p = 0.04) and (p = 0.002) respectively. Myocardial
performance index (Tei index) of the LV and RV
derived by TDI was significantly higher in the
studied group than the control group (both
p < 0.0001.
Serum 25(OH)D level showed significant nega-
tive correlation with serum BNP level (r = 0.770,
p < 0.0001; Fig. 2), LV Tei index (r = 0.668,













r= - 0.421, p<0.0001
Figure 4. Negative correlation between serum 25-hydroxyvitamin D
(25(OH)D) level and tissue Doppler imaging-derived right ventric-
ular (RV) Tei index.

















r = 0.606; p< 0.0001
Figure 6. Positive correlation between serum 25-hydroxyvitamin D
(25(OH)D) level and tissue Doppler imaging-derived mitral peak
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p < 0.0001; Fig. 4) and LVIDd (r = 0.320,
p = 0.004; Fig. 5), while significant positive correla-
tion was found between serum 25(OH)D level and
mitral annular Sm velocity (r = 0.606, p < 0.0001;
Fig. 6). By contrast, no significant correlation was
found between serum 25(OH)D level and FS












r = - 0.320, p = 0.004
Figure 5. Negative correlation between serum 25-hydroxyvitamin D
(25(OH)D) level and left ventricular diameter at end diastole
(LVIDd).Discussion
To the best of our knowledge, this is the first
study to assess the utility of TDI in healthy adoles-
cents with vitamin D deficiency. Our results
support the use of TDI as a useful diagnostic tool
for myocardial dysfunction in those patients.
Decreased atrioventricular Sm velocities together
with higher ICT for both left and right ventricles
in vitamin D deficient adolescents indicated LV
and RV systolic dysfunction in this age group.
The changes in atrioventricular Em and Am veloc-
ities, Em/Am ratio, E/Em ratio and IRT indicated
altered diastolic function in the vitamin D defi-
cient group. The E/Ea ratio is the best parameter
to predict the mean LV filling pressures [12], and
it is proportional to the severity of LV diastolic
dysfunction. It showed significant alteration in
the vitamin D deficient group compared with the
control and together with significant reduced
mitral Em velocity gave important information
about the diastolic function of the LV. Similar tri-
cuspid E/Em ratio alteration has been noted, indi-
cating changes in the right ventricular diastolic
function in the vitamin D deficient group. The
TDI indexes of global myocardial function (RV
and LV Tei indexes) were significantly higher in
the vitamin D deficient group, indicating compro-
mised global systolic and diastolic function. TDI
was more sensitive than conventional echocardio-
graphy in detecting global myocardial dysfunc-
tion. Tei index has been reported to be useful
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sure, or ventricular geometry [13,14]. It has been
used to analyze systolic and diastolic global ven-
tricular function in various congenital and
acquired cardiac abnormalities in neonates and
children [14]. We have demonstrated that serum
25(OH)D levels correlated negatively with RV
and LV Tei indexes, while there was a positive cor-
relation with mitral peak Sm velocity. By contrast,
no significant correlation was found between
serum 25(OH)D level and FS. Conventional
echocardiography appeared to be less valuable
for the early detection of abnormal myocardial
function in patients with vitamin D deficiency as
there were no statistically significant differences
in systolic and diastolic function of LV and RV.
Armstrong et al. studied myocardial contractility
in neonates with severe vitamin D deficiency
using TDI measures of systolic and diastolic veloc-
ity and concluded that severe vitamin D defi-
ciency appears to cause no impairment in
myocardial contractility when comparing these
neonates to those with normal levels [15]. A study
of left ventricular function in infants and children
with nutritional vitamin D deficiency rickets
demonstrated echocardiographic evidence of left
ventricular dysfunction. These abnormalities were
not, however, sufficiently severe to be associated
with clinical signs of cardiac failure. This finding
may return to normal following adequate treat-
ment of the rickets [16]. Two-dimensional
echocardiography was used to measure the left
ventricular mass index, E/A ratio, Em, E/Em ratio,
and myocardial performance index in pediatric
patients with chronic kidney disease and nutri-
tional vitamin D deficiency. These patients
showed increased left ventricular mass and severe
diastolic dysfunction, which may be irreversible
[17]. It has been postulated that vitamin D affects
cardiovascular function via multiple mechanisms.
Experimental studies have suggested that vitamin
D can regulate the growth and proliferation of car-
diomyocytes and vascular smooth muscle cells. It
has been shown in neonatal rat hearts that
activated vitamin D might act via a protein
kinase-dependent mechanism to inhibit car-
diomyocytes maturation [18] and proliferation
[19]. Observational studies support the concept
that vitamin D deficiency is involved in the patho-
genesis of congestive heart failure [20].
We found significant negative correlation
between serum 25(OH)D and serum BNP levels.
In studies of experimental animals, activation of
nuclear vitamin D receptors by 1,25(OH)2D3 sup-
presses the expression and secretion of atrialnatriuretic peptide (ANP) and BNP in cardiac
myocytes [21,22], while in clinical studies of non-
dialysis chronic kidney disease patients, individu-
als treated with 1,25(OH)2D3 for 12 weeks were
observed to have improved left ventricular dias-
tolic function as compared with placebo [23]. In
animal models of heart failure, active vitamin D
treatment was shown to reduce cardiac hypertro-
phy, attenuate myocardial dysfunction and sup-
pressed the secretion of the cardiac natriuretic
peptides [24]. Several genes that are upregulated
in the course of cardiac hypertrophy, involving
those of natriuretic peptides and renin, are down-
regulated by vitamin D [24]. Importantly, there
exists increasing molecular and clinical evidence
that a sufficient vitamin D status is required for
maintenance of diastolic function of the heart
[24,25]. Although vitamin D supplementation in
adults with congestive heart failure did not
improve physical performance as measured by
peak oxygen consumption [26], there are several
case reports of vitamin D deficient children with
dilated cardiomyopathy that could be successfully
treated with vitamin D and calcium [27]. Vitamin
D supplementation was beneficial in treatment
of congestive heart failure, as demonstrated by a
recent double-blind placebo-controlled study [28].
Lower serum calcium level together with higher
iPTH level was found in vitamin D deficient ado-
lescents. The inverse relationship of increasing
iPTH with decreasing 25(OH)D concentrations
has been demonstrated in older children and ado-
lescents [29]. The extent of vitamin D deficiency
has been suggested by reports from other regions
of the world, including children and adolescents
living in Germany, Turkey, Finland, and Ireland
[30–32]. With lower 25(OH)D concentrations
correlating with increased iPTH concentrations,
vitamin D deficiency could result in secondary
hyperparathyroidism. This condition would
deplete the bone of mineral, especially during
periods of accelerated bone growth, and lead to
long-term detrimental effects [33].
Solar UV-B radiation is the major source of vita-
min D for humans. Consequently, the vitamin D
status is largely influenced by season, geographic
latitude, daily outdoor activities, and the percent-
age of body surface exposed to solar UV-B. A
significant proportion of individuals in Europe
and North America have vitamin D concentrations
in the deficiency range [25(OH)D < 25 nM].
Available data indicate that low solar UV-B
exposure and/or low 25(OH)D concentrations are
associated with an increased risk of cardiovascular
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women and in younger age groups [34]. The lack
of sun exposure in eastern area in Saudi Arabia
due to the wearing of traditional clothes and
deliberate avoidance of the sun, and inadequate
dietary intake are likely to be the principal causes
of low vitamin D levels. Adolescents are at high
risk of vitamin D deficiency due to the increased
metabolic demand of rapid growth during this
period, so pediatricians and other health care pro-
fessionals should strive to make vitamin D supple-
ments readily available to all children and
adolescents and encourage sun exposure where
possible.Limitations
This study included a small number of patients,
so we believe that multicenter studies with an
adequate number of patients is required to power
the study sufficiently and further delineate the
relationship between serum vitamin D level and
myocardial function. Additionally, TDI is angle
dependent, so recent modalities of echocardio-
graphic assessment of left and right ventricles
can be used including strain rate imaging.Conclusion
Vitamin D deficiency in is associated with subtle
systolic and diastolic myocardial dysfunction in
Saudi adolescents. TDI is a useful tool for detect-
ing early changes in the myocardium in this par-
ticular group.References
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